1. Home
  2. ACIW vs APGE Comparison

ACIW vs APGE Comparison

Compare ACIW & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ACI Worldwide Inc.

ACIW

ACI Worldwide Inc.

HOLD

Current Price

$41.87

Market Cap

4.3B

Sector

Technology

ML Signal

HOLD

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$87.91

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACIW
APGE
Founded
1975
2022
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
4.7B
IPO Year
1996
2023

Fundamental Metrics

Financial Performance
Metric
ACIW
APGE
Price
$41.87
$87.91
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
13
Target Price
$62.50
$109.67
AVG Volume (30 Days)
685.8K
791.9K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
13.09
N/A
EPS
2.16
N/A
Revenue
$1,009,780,000.00
N/A
Revenue This Year
$9.67
N/A
Revenue Next Year
$7.41
N/A
P/E Ratio
$20.45
N/A
Revenue Growth
N/A
N/A
52 Week Low
$38.05
$34.34
52 Week High
$55.45
$95.32

Technical Indicators

Market Signals
Indicator
ACIW
APGE
Relative Strength Index (RSI) 49.96 59.90
Support Level $38.70 $73.06
Resistance Level $43.01 N/A
Average True Range (ATR) 1.34 3.36
MACD 0.23 -0.08
Stochastic Oscillator 39.16 48.34

Price Performance

Historical Comparison
ACIW
APGE

About ACIW ACI Worldwide Inc.

ACI Worldwide Inc develops, markets, and installs a portfolio of software products focused on facilitating electronic payments. The firm's products are sold and supported directly and through distribution networks covering three geographic regions - the Americas, EMEA, and Asia Pacific. ACI software products process payment transactions for retail banking clients, billers such as utilities and healthcare providers, and community banks and credit unions. ACI's customers are financial institutions all over the world, but the majority of the revenue is generated in the United States and EMEA regions. The company's operating segment includes Payment Software and Biller. The company generates the majority of its revenue from the Payment Software segment.

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Share on Social Networks: